After the stock market closed on Tuesday, Sarepta
After the stock market closed on Tuesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) reported a bigger-than-expected loss of $88.5 million or $1.62 per share. In addition, investors are questioning their ability to fully launch and profit from upcoming drugs, offsetting future losses as they burn through cash. The stock took a beating after-hours, dropping almost 15% to below $27 per shares. As investors are freaking out, those of us not currently invested in the stock have a chance to make a wise decision. The company still has huge drugs in its pipeline and over $300 million in cash. The key is finding the right buy level. The first major support on the stock is at $24.00. That would be the first spot to accumulate a small position. I would recommend accumulating all the way down to $20, then looking for positive drug news to drive the stock above $40.
Stock chart analysis on Sarepta Therapeutics after crushed
Sarepta Therapeutics Inc. (SRPT) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
iAnthus Capital Holdings Inc. Announces Q2 2025 Results iAnthus Capital Holdings, Inc. is a prominent player in the cannabis industry, operating across various states in the U.S. They have recently shared their financial results for the second quarter of 2025. This report outlines the company’s financial health, revealing key insights into revenue and earnings amid...
Continue Reading
Tesla's Stock Sees Pullback Following Robotaxi Reveal Tesla, Inc. (NASDAQ: TSLA) found itself in a precarious position in pre-market trading as shares dipped sharply. This downturn came in the wake of a much-anticipated event showcasing the company's Robotaxi, dubbed “We, Robot.” Despite the excitement surrounding the autonomous vehicle, the unveil did not produce the...
Continue Reading
Mexico Stock Market Overview The stock market in Mexico is experiencing notable gains, signaling a healthy economic environment and investor confidence. On the most recent trading day, the market sentiment was buoyed by strong performance across various sectors. S&P/BMV IPC Performance The S&P/BMV IPC ended up 0.46%, marking a positive closing for investors. Key sectors...
Continue Reading
Project Kesher's Empowerment Focus at Davos Project Kesher, a distinguished nonprofit organization dedicated to advocating for women's rights, is making significant strides at the World Economic Forum Annual Meeting in Switzerland. Since its establishment in 1989, the organization has worked tirelessly to elevate the status of women, foster civil society, and revitalize...
Continue Reading
Centene Corporation's Legal Troubles Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is currently facing serious legal issues. A recent lawsuit filed against the company and some of its senior executives has raised concerns about potential violations of federal securities laws. What Prompted the Lawsuit? The lawsuit, initiated by the...
Continue Reading
